Add To Watchlist
Share URL
About The Company
CEO
Mr. Hector Bremner
Market Cap
22.19 Million USD
Sector
Healthcare
Website
https://www.avricorehealth.comDescription
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada.
Read More
Overview
Value
1
Growth
56
Health
51
Management
60
Analyst Opinion
63
Total
46
All Scores Out Of 100
Best Features
- Earnings growth has improved recently
- Has a low level of debt
- Low risk of bankruptcy
- Low preportion of income is paid as dividend 0
Risk Factors
- Overvalued on cashflow basis
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders
- No margin of safety at their current market price
Latest News

Avricore Health is empowering patients to make proactive healthcare decisions with its point-of-care testing platform HealthTab
Proactive Investors | 12:00 Fri 20 Jan 2023
Read More →

Avricore Health sees 3Q revenue soar by 662% as it successfully scales its HealthTab network
Proactive Investors | 22:13 Tue 6 Dec 2022
Read More →

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) on Mission to Make Health Info Accessible to All
GlobeNewsWire | 14:30 Thu 14 Oct 2021
Read More →

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Wheelhouse at Center of Nascent Industry
GlobeNewsWire | 14:30 Wed 13 Oct 2021
Read More →
Market Peers
AVCRF
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-101.13%
Revenue Growth (5 Year Average)
12.71%
Ratings Consensus
Neutral
Share Buybacks
-39.84%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: N/A✘
Current Price: 0.2 USD
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-4.98%
PE/Earnings Growth
N/A
Price/Book
12.67x
Growth
Growth Score
56
- ✔ 5 Year Average Revenue growth of 12.71% is higher than the market average (10.97%)
- ✔ Revenue growth has improved this yeara
- ✔ 5 Year Average Earnings growth of 23.25% is higher than the market average (14.48%)
- ✔ Earnings growth has improved this year
- ✘ 5 Year Average Free Cashflow growth of 5.01% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
12.71%
Earnings Growth
23.25%
Cashflow Growth
5.01%
Health
Health Score
51
Altman Z Score
14.78
Piostroski Score
3.00
Debt/Equity
0.02x
Current Assets/Liabilities
25.56x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.02x
Management
Management Score
60
Average Buybacks/Dilution
-39.84%
Recent Buybacks/Dilution
6.49%
5 Year Price Volitility
81.86%
Return On Assets
-86.46%
Return On Capital Employed
-69.05%
Return On Equity
-89.78%
Return On Free Cashflow
161.22%
Return On Investments
N/A
Analysts
Analyst Opinion
63
- ✔ Ratings consensus is Neutral
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Avricore Health Inc.
Currency
USD
Beta
-2.132832
Vol Avg
1615
Ceo
Mr. Hector Bremner
Cik
0001355736
Cusip
054521109
Exchange
Other OTC
Full Time Employees
Industry
Diagnostics & Research
Sector
Healthcare
Ipo Date
2018-12-14
Address
789 West Pender Street
City
Vancouver
State
BC
Country
CA
Zip
V6C 1H2
Phone
All financial data provided by FMP